Riboflavin Market Analysis 2026

Global Riboflavin Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Riboflavin Market Report Description

We have various report editions of Riboflavin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Riboflavin Market Insights Video

Competitive Landscape of the Riboflavin Market

The riboflavin industry is fiercely competitive, with major competitors prioritizing innovation, economical production techniques, and diversifying their product lines. With robust international distribution networks, industry leaders BASF SE, DSM, and Guangji Pharmaceutical dominate the market. Regional producers and smaller businesses also compete by providing more specialized or affordable solutions. Companies frequently engage in strategic alliances, mergers, and acquisitions in an effort to increase their market share and satisfy the rising demand for riboflavin products from consumers.

In January 2023, BASF announced that it would invest in increasing the capacity of its polymer dispersions manufacturing facility in Merak, Indonesia. (Source:https://www.basf.com/in/en/media/news-releases/asia-pacific/2023/01/basf-invests-in-the-expansion-of-the-polymer-dispersions-busines) In November 2022, DSM began building a large-scale production plant in Dalry, Scotland, to produce Bovaer®, a unique feed additive for ruminants that lowers methane. (Source: https://www.dsm.com/anh/news/press-releases/2022/2022-11-30-dsm-starts-construction-of-large-scale-production-facility-for-bovaer-in-dalry-scotland.html) In December 2021, a study from Kobe University discovered that vitamin B2 supplementation improved the mitochondria's capacity to generate energy, hence delaying the aging process of cells subjected to aging stress. (Source: https://www.kobe-u.ac.jp/en/news/article/2021_12_13_01/)

Top Companies Market Share in Riboflavin Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Riboflavin Market

Which Region Dominates the Riboflavin Market in 2024?

According to Cognitive Market Research, North America currently dominates the Riboflavin market, and the region is expected to have significant growth during the projected period. Due to the rise in the market for dietary supplements and increased health consciousness, North America is predicted to lead the growth of the riboflavin (vitamin B2) market. The market for riboflavin-enriched products is being driven by the region's strong emphasis on preventative healthcare and an older population that is striving to preserve optimal health. Further promoting market expansion is the extensive use of riboflavin in animal feed, medications, and food fortification in the United States and Canada. The demand for riboflavin in North America is also largely driven by the region's well-established healthcare system and government programs that support foods high in vitamins.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Owing to an increase in disposable money, greater health perception, and growing awareness of nutritional inadequacies, the Asia-Pacific region is expected to propel significant growth in the riboflavin (vitamin B2) market. Demand for nutritional supplements and fortified foods is rising in the region due to its vast population and developing middle class, especially in China and India. Furthermore, the use of riboflavin in food fortification programs is being encouraged by government attempts to prevent malnutrition and vitamin deficiencies. Asia-Pacific is a major driver of the riboflavin market's growth due to the region's burgeoning pharmaceutical and animal feed sectors, particularly in China and Southeast Asia.

The current report Scope analyzes Riboflavin Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Riboflavin Market Analysis

According to Cognitive Market Research, the global Riboflavin market size was estimated at USD 415.8 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 166.32 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Riboflavin market with a market size of USD 131.23 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. The demand for riboflavin-enriched foods and drinks is rising in the United States market, which is heavily focused on preventative healthcare.
• The Canadian riboflavin market had a market share of USD 19.96 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. The growing number of Canadians who are concerned about their health is driving rising demand for riboflavin as an ingredient in multivitamin supplements.
• The Mexico Riboflavin market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 15.14 million in 2024.

Europe Riboflavin Market Analysis

According to Cognitive Market Research, the global Riboflavin market size was estimated at USD 415.8 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 124.74 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• The United Kingdom Riboflavin market had a market share of USD 20.96 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. In the UK, An increase in plant-based diets has led to a surge in the requirement for riboflavin supplements among people whose diets might not be providing enough B2.
• The France Riboflavin market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 11.48 million in 2024.
• According to Cognitive Market Research, the German Riboflavin market size was valued at USD 24.70 million in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period. In Germany, the country's overall market expansion is aided by the use of riboflavin in vitamin supplements and medications to treat deficiencies.
• The Italy Riboflavin market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 10.73 million in 2024.
• The Russian riboflavin market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 19.33 million in 2024.
• The Spain Riboflavin market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 10.23 million in 2024
• The Luxembourg Riboflavin market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 3.87 million in 2024.
• The Portugal Riboflavin market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 2.62 million in 2024.
• The Greece Riboflavin market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 1.50 million in 2024.
• The Rest of Europe's Riboflavin market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 19.33 million in 2024.

Asia Pacific Riboflavin Market Analysis

According to Cognitive Market Research, the global Riboflavin market size was estimated at USD 415.8 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 95.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Riboflavin market size was valued at USD 43.04 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Riboflavin sales surged in China due to the need for riboflavin supplements and fortified foods to achieve daily nutritional requirements is driven by the prevalence of vitamin deficiencies in rural areas.
• The Japan Riboflavin market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 13.20 million in 2024.
• The India Riboflavin market had a market share of USD 11.48 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Indian consumers are increasingly using dietary supplements and fortified foods to increase their intake of riboflavin as their disposable income rises.
• The South Korean Riboflavin market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 9.56 million in 2024.
• The Australian Riboflavin market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 4.97 million in 2024.
• The South East Asia Riboflavin market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 6.60 million in 2024.
• The Rest of Asia Pacific Riboflavin market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 6.79 million in 2024.

South America Riboflavin Market Analysis

According to Cognitive Market Research, the global Riboflavin market size was estimated at USD 415.8 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 20.79 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Riboflavin market size was valued at USD 8.90 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Riboflavin flourished in Brazil because Brazil’s focus on enhancing public health through the fortification of staple commodities like bread and dairy with riboflavin is a major driving factor.
• Argentina's Riboflavin market had a market share of USD 3.49 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In Argentina, there is a growing consumer demand for high-quality dairy and meat products.
• Colombia Riboflavin market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 1.85 million in 2024.
• Peru Riboflavin market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 1.70 million in 2024.
• Chile's Riboflavin market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 1.50 million in 2024.
• The Rest of Latin America's Riboflavin market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 3.35 million in 2024.

Middle East Riboflavin Market Analysis

According to Cognitive Market Research, the global Riboflavin market size was estimated at USD 415.8 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 8.32 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031..

• The GCC Countries Riboflavin market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 3.56 million in 2024. Riboflavin sales flourish in GCC countries because the demand for riboflavin is rising as a result of the GCC countries' governments encouraging the use of nutritional supplements and fortified foods to enhance public health.
• The Egypt Riboflavin market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 0.87 million in 2024.
• The South African riboflavin market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 1.31 million in 2024. Riboflavin sales flourished in South Africa due to opportunities for companies in the tourism industry to sell products based on riboflavin.
• The Turkey Riboflavin market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 0.72 million in 2024.
• The Nigeria Riboflavin market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 0.87 million in 2024.
• The Rest of the MEA Riboflavin market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 0.98 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.